The folks at the Multidisciplinary Association for Psychedelic Studies (MAPS) did a Reddit AMA yesterday. I’ve curated some of the more informative questions and answers, but you can read the entire thread here.
MAPS introduces themselves with this lengthy but informative opening:
… Read the rest
We are the Multidisciplinary Association for Psychedelic Studies (MAPS), and we are here to educate the public about research into the risks and benefits of psychedelics and marijuana. MAPS is a 501(c)(3) non-profit research and educational organization founded in 1986 that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
We envision a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.
Some of the topics we’re passionate about include;
- Research into the therapeutic potential of MDMA, LSD, psilocybin, ayahuasca, ibogaine, and marijuana
- Integrating psychedelics and marijuana into science, medicine, therapy, culture, spirituality, and policy
- Providing harm reduction and education services at large-scale events to help reduce the risks associated with the non-medical use of various drugs
- Ways to communicate with friends, family, and the public about the risks and benefits of psychedelics and marijuana
- Our vision for a post-prohibition world
- Developing psychedelics and marijuana into prescription medicines through FDA-approved clinical research
List of participants:
- Rick Doblin, Ph.D., Founder and Executive Director, MAPS
- Brad Burge, Director of Communications and Marketing, MAPS
- Amy Emerson, Executive Director and Director of Clinical Research, MAPS Public Benefit Corporation
- Virginia Wright, Director of Development, MAPS
- Brian Brown, Communications and Marketing Associate, MAPS
- Sara Gael, Harm Reduction Coordinator, MAPS
- Natalie Lyla Ginsberg, Research and Advocacy Coordinator, MAPS
- Tess Goodwin, Development Assistant, MAPS
- Ilsa Jerome, Ph.D., Research and Information Specialist, MAPS Public Benefit Corporation
- Sarah Jordan, Publications Associate, MAPS
- Bryce Montgomery, Web and Multimedia Associate, MAPS
- Shannon Clare Petitt, Executive Assistant, MAPS
- Linnae Ponté, Director of Harm Reduction, MAPS
- Ben Shechet, Clinical Research Associate, MAPS Public Benefit Corporation
- Allison Wilens, Clinical Study Assistant, MAPS Public Benefit Corporation
- Berra Yazar-Klosinski, Ph.D., Clinical Research Scientist, MAPS
For more information about scientific research into the medical potential of psychedelics and marijuana, visitmaps.org.